Viking Therapeutics Correlations

VKTX Stock  USD 52.59  0.96  1.86%   
The current 90-days correlation between Viking Therapeutics and Reata Pharmaceuticals is -0.13 (i.e., Good diversification). The correlation of Viking Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Viking Therapeutics Correlation With Market

Modest diversification

The correlation between Viking Therapeutics and DJI is 0.22 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Viking Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Viking Stock please use our How to Invest in Viking Therapeutics guide.

Moving against Viking Stock

  0.48RNXT RenovoRxPairCorr
  0.33MDGL Madrigal PharmaceuticalsPairCorr
  0.36PG Procter GamblePairCorr
  0.32JPM JPMorgan Chase Fiscal Year End 10th of January 2025 PairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
PTCTAKRO
IMGNPTCT
IMGNAKRO
MDGLRETA
SRPTICPT
HEPAICPT
  
High negative correlations   
IMGNICPT
IMGNSRPT
PTCTICPT
AKROICPT
IMGNHEPA
PTCTTERN

Risk-Adjusted Indicators

There is a big difference between Viking Stock performing well and Viking Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Viking Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ICPT  2.96 (0.77) 0.00  8.23  0.00 
 5.23 
 38.17 
TERN  3.37 (0.50) 0.00 (0.29) 0.00 
 5.68 
 34.09 
AKRO  2.39  0.13  0.09  0.18  2.66 
 5.23 
 13.37 
RETA  2.22  0.21  0.02 (1.50) 3.31 
 5.24 
 28.80 
MDGL  2.68  0.54  0.19  1.52  2.09 
 5.17 
 30.27 
SRPT  1.37 (0.41) 0.00 (0.40) 0.00 
 2.37 
 9.65 
HEPA  3.82 (0.35) 0.00 (0.15) 0.00 
 8.06 
 33.54 
PTCT  2.29  0.25  0.11  0.28  2.43 
 5.65 
 23.95 
AXSM  1.72  0.13  0.04  0.32  1.89 
 4.10 
 13.67 
IMGN  5.45  3.62  1.07 (0.59) 1.44 
 8.32 
 141.41 

Viking Therapeutics Corporate Management

CPA CPAChief OfficerProfile
Michael MorneauVice AdministrationProfile
Marianne ManciniChief OfficerProfile
Geoffrey BarkerSenior DevelopmentProfile